Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
University of Pennsylvania researchers called on computational systems biology expertise at 91°µÍø to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
A multi-institutional team, led by a group of investigators at 91°µÍø, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease.
Scientists from 91°µÍø used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
A team led by Dan Jacobson of 91°µÍø used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.